Medication Assisted Weightloss

Semaglutide is a Glucagon-like peptide-1 (GLP-1 ) produced by the gut. It increases insulin production, a hormone that lowers the blood sugar level while inhibiting glucagon secretion, which is a hormone that raises blood sugar, reduces appetite and energy intake while delaying gastric emptying.

HOW DOES THIS MEDICATION WORK?

• They slow down food movement through the intestine, enabling people to feel full for a longer period.

• They help lower blood sugar by making insulin work better, thus reducing the impact of insulin, a hormone that stimulates obesity.

• They also suppress the part of the brain that drives food cravings.

SEMAGLUTIDE FOR WEIGHT LOSS

Semaglutide originally came to market as a drug to treat diabetes. Its brand name is Ozempic when used for diabetes. When used for obesity, its brand name is Wegovy. It belongs to a class of drugs known as glucagon-like peptide 1(GLP-1). These drugs were introduced to the market in 2005.

More recently, research studies have enabled the drugs to become FDA-approved for treating obesity. In comparative studies, semaglutide appears to have been the most beneficial for weight loss within this class. The semaglutide received will not be brand name and will be from a compounding pharmacy that is FDA regulated. The drug is approved for long-term use. In most

cases, patients will cycle on and off the medication as needed to keep their weight at its best level.

​

  Tirzepatide Information 

Tirzepatide is a GIP and a Glucagon-like peptide-1 (GLP-1) produced by the gut. It increases insulin production, a hormone that lowers the blood sugar level while inhibiting glucagon secretion, which is a hormone that raises blood sugar, reduces appetite and energy intake while delaying gastric emptying. Tirzepatide also decreases blood sugar levels by increasing insulin production and lowering the amount of sugar the liver makes. 

HOW DOES THIS MEDICATION WORK?

• They slow down food movement through the intestine, enabling people to feel full for a longer period.

• They help lower blood sugar by making insulin work better, thus reducing the impact of insulin, a hormone that stimulates obesity.

• They also suppress the part of the brain that drives food cravings.

TIRZEPATIDE FOR WEIGHT LOSS

Tirzepatide originally came to market as a drug to treat diabetes. Its brand name is Mounjaro when used for diabetes. When used for obesity, its brand name is Zepbound. It belongs to a class of drugs known as GIP (glucose-dependent insulinotropic polypeptide) and glucagon-like peptide 1(GLP-1). These drugs were introduced to the market in 2022. The Tirzepatide received will not be brand name and will be from a compounding pharmacy that is FDA regulated. Tirzepatide if often used when results utilizing Semaglutide are not desirable.  In most cases, patients will cycle on and off the medication as needed to keep their weight at its best level.

​

​